Convexity Labs

BRP

Convexity Analyst · BRP
medium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: BRP GROUP, INC. (BRP) DATE: 2026-06-13 CURRENT PRICE: $32.66

1. Structural Readiness

State: Context-Only Conservative Entry:Breakout Level:Extension:ATR Current: 3.7% (Productive)

Analysis: As of the close on 2026-06-13, the structural setup for BRP Group, Inc. is context-only. There is no active, forming, or invalidated coil structure defined in the current data feed.

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None.

There is no named secular thesis attached to BRP Group, Inc. as of this date. The investment case is strictly tactical and setup-led.

  • Judgment Criteria: The name must be judged solely on the quality of its immediate setup (which is currently absent) and the strength of its underlying business fundamentals.
  • Constraint: No macro or secular themes (e.g., "AI in insurance," "Demographic shift") should be invented to force a conviction. The conviction must derive from the visible evidence of execution and the eventual formation of a structural setup.

3. The Business

Company Overview: BRP Group, Inc. is an insurance provider operating across the United States. Its operations are organized into four distinct divisions: Middle Market, Specialty, MainStreet, and Medicare.

Business Model & Segments:

  • Middle Market: Targets mid-sized to large enterprises, high-net-worth individuals, and families. It offers solutions in commercial risk management, employee benefits, and private risk protection.
  • Specialty: Serves specialized insurers, professionals, and niche industry businesses. It provides sophisticated underwriting and tailored placement programs. Notably, this segment functions as a managing general agent for the "Future" platform, delivering proprietary, technology-enabled insurance solutions.
  • MainStreet: Focuses on local communities, providing personal, commercial, and life/health insurance products to individuals and businesses.
  • Medicare: Assists seniors and Medicare-eligible individuals with government assistance programs (Medicare and Medicare Advantage) through a vast network of independent contractor agents.

Recent Execution & Fundamentals (Source: Earnings Transcript, 2026-05-04): Management has provided specific guidance and execution metrics as of the Q2 2026 earnings call:

  • Revenue Guidance: For Q2 2026, management expects revenue of $485 million to $490 million, with organic revenue growth in the mid-single digits.
  • Profitability Guidance: Adjusted EBITDA is anticipated between $113 million and $118 million, with adjusted diluted EPS of $0.44 to $0.48.
  • Cost Synergies: Over $34 million in cost synergies have been actioned, representing nearly 80% of the three-year $43 million target.
  • Revenue Synergies: The company realized $1 million in revenue synergies in the quarter, growing to nearly $3 million as of the call date, with over $10 million in client cross-sell opportunities actively being worked.
  • Segment Growth:
  • CAC (Commercial Agency/Cross-sell): Generated new business of $38 million in Q1 2026, up 39% year-over-year. Total revenue for this segment was $92 million, representing 27% growth relative to 2025.
  • Operational Efficiency: Executed the first phase of role transformation within IAS, on track to deliver $3 million to $5 million in in-year savings.
  • New Initiatives: Embedded mortgage businesses went live in April with Fairway Independent Mortgage (a top-10 independent originator).
  • Scale Advantages: Multifamily business grew revenue 10% in the quarter; Juniper Re grew over 90%.

4. Archetype and Conviction

Archetype: Growth Leader Fit: The name fits the Growth Leader archetype based on the evidence of accelerating revenue in key segments (CAC +39%, Juniper Re +90%) and the successful execution of a multi-year synergy program (80% complete). The business model demonstrates a shift toward technology-enabled solutions (Future platform, embedded mortgage) and high-growth niche markets (Juniper Re).

Valuation & Financial Context:

  • Forward Consensus: The financial spine indicates a Forward Consensus EPS (FY1) of $2.70.
  • FY2 Data: FY2 consensus is listed as 0, indicating a lack of analyst coverage or data for the second forward year as of this date.
  • Conviction Stack:
  • Thesis Strength: Low (No macro thesis; purely tactical).
  • Evidence Quality: High (Specific, quantified guidance and synergy data from primary earnings transcripts).
  • Structural Quality: None (No setup defined).
  • Rerating Potential: Dependent on the formation of a structural setup. The fundamental momentum (synergies, growth) is strong, but the market structure is currently undefined.

ATR Context: Current ATR is 3.7%, which falls within the productive range (historically 4–6% is the sweet spot, but 3.7% is acceptable for sizing if a setup forms). However, without a breakout level, the "ATR at breakout" metric is unavailable.

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate the Case:

  • Fundamental: A miss on the Q2 2026 revenue guidance ($485M–$490M) or a significant slowdown in the synergy capture rate (falling below the 80% target trajectory).
  • Operational: Failure to realize the $10M in cross-sell opportunities or a decline in the CAC new business growth rate.

What Would Strengthen the Case:

  • Fundamental: Confirmation that the "Future" platform or embedded mortgage business scales beyond the initial launch with Fairway.
  • Synergy: Acceleration of the remaining 20% of the $43M synergy target ahead of schedule.

Gaps in Evidence:

  • Forward Year Data: The FY2 EPS consensus is 0, limiting the ability to assess long-term valuation multiples beyond the current fiscal year.
  • Sector Classification: The specific sector and industry classification are not provided in the evidence cache, limiting peer-relative analysis.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Management guidance for Q2 revenue ($485M-$490M) and EBITDA ($113M-$118M); 80% of $43M synergy target already actioned; CAC new business up 39% YoY. Key risks: No structural setup defined (context-only state); FY2 earnings consensus is zero; lack of named secular thesis to support multiple expansion. Expected path: Management continues to execute on the remaining 20% of synergy targets and scales the embedded mortgage and Future platform initiatives; price action eventually coalesces into a consolidation pattern. Expected horizon: 3 to 6 months for structural setup formation.

Loading chart...
Exhibit 1: BRP daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for BRP.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for BRP.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: